Bristol-Myers Squibb (BMY)

1096271 BC ULC • 345 Park LLC • 9643435 Canada Inc. • Abraxis BioScience Australia Pty Ltd. • Abraxis BioScience International Holding Company, Inc. • Abraxis BioScience Puerto Rico, LLC • Abraxis BioScience, Inc. • Abraxis BioScience, LLC • AbVitro LLC • Adnexus, a Bristol-Myers Squibb R&D Company ...

IRS number

220790350

BMY stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$65.00

Low target

$62.00

High target

$70.00

Latest filings (excl ownership)

View all

8-K

Departure of Directors or Certain Officers

12 Feb 25

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024

6 Feb 25

8-K

43rd Annual J.P. Morgan Healthcare Conference January 13th, 2025 Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer

13 Jan 25

S-3ASR

Automatic shelf registration

31 Oct 24

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

26 Jul 24

Bristol Myers Squibb Reports Second Quarter Financial Results for 2024

26 Jul 24

8-K

Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors

18 Jun 24

Transcripts

View all

BMY

Earnings call transcript

2024 Q4

6 Feb 25

BMY

Earnings call transcript

2024 Q3

31 Oct 24

BMY

Earnings call transcript

2024 Q2

26 Jul 24

BMY

Earnings call transcript

2024 Q1

25 Apr 24

BMY

Earnings call transcript

2023 Q4

2 Feb 24

BMY

Earnings call transcript

2023 Q3

26 Oct 23

BMY

Earnings call transcript

2023 Q2

27 Jul 23

BMY

Earnings call transcript

2023 Q2

27 Jul 23

BMY

Earnings call transcript

2023 Q1

27 Apr 23

BMY

Earnings call transcript

2022 Q4

2 Feb 23

Latest ownership filings

View all

CHRISTOPHER S. BOERNER

Theodore R. Samuels II

Financial summary

Financial statements Chart BMY financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	10.35 bn	10.35 bn	10.35 bn	10.35 bn	10.35 bn	10.35 bn
Cash burn (monthly)	(no burn)	97.67 mm	(no burn)	678.08 mm	(no burn)	(no burn)
Cash used (since last report)	n/a	203.22 mm	n/a	1.41 bn	n/a	n/a
Cash remaining	n/a	10.14 bn	n/a	8.94 bn	n/a	n/a
Runway (months of cash)	n/a	103.9	n/a	13.2	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

BMY institutional ownership history Ownership history

78.2% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2401	2235	+7.4%
Opened positions	328	271	+21.0%
Closed positions	162	158	+2.5%
Increased positions	899	802	+12.1%
Reduced positions	897	911	-1.5%

13F shares	Current	Prev Q	Change
Total value	85.68 tn	73.72 tn	+16.2%
Total shares	1.59 bn	1.51 bn	+5.0%
Total puts	27.82 mm	34.85 mm	-20.2%
Total calls	27.33 mm	31.44 mm	-13.1%
Total put/call ratio	1.0	1.1	-8.2%

Largest owners	Shares	Value	Change
Vanguard	189.94 mm	$10.74 tn	+0.7%
BlackRock	157.61 mm	$8.91 tn	-1.3%
JPM JPMorgan Chase & Co.	96.02 mm	$5.43 tn	+23.2%
STT State Street	95.14 mm	$5.38 tn	+2.4%
Charles Schwab Investment Management	60.30 mm	$3.41 tn	-1.2%
Capital International Investors	45.87 mm	$2.59 tn	+7.5%
Geode Capital Management	44.39 mm	$2.51 tn	+2.7%
Norges Bank	35.18 mm	$1.99 tn	NEW
AMP Ameriprise Financial	32.08 mm	$1.81 tn	+59.9%
FMR	31.11 mm	$1.76 tn	-30.8%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	35.18 mm	+35.18 mm	NEW
JPM JPMorgan Chase & Co.	96.02 mm	+18.09 mm	+23.2%
FMR	31.11 mm	-13.83 mm	-30.8%
T. Rowe Price	7.53 mm	-12.71 mm	-62.8%
AMP Ameriprise Financial	32.08 mm	+12.01 mm	+59.9%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	12.47 mm	+10.91 mm	+701.2%
Two Sigma Advisers	1.86 mm	-7.69 mm	-80.5%
Wellington Management	5.98 mm	+5.83 mm	+3880.0%
Citadel Advisors	41.54 k	-5.04 mm	-99.2%
Two Sigma Investments	85.62 k	-4.64 mm	-98.2%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BMY insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
20 Feb 25	Boerner Christopher S.	Common Stock, $0.10 par value	Buy	Acquire P	No	No	55.048	2,000	110.10 k	104,626
14 Feb 25	Hirawat Samit	Common Stock, $0.10 par value	Buy	Acquire P	No	No	54.84	1,823.486	100.00 k	63,932.486
1 Feb 25	Gregory Scott Meyers	Common Stock, $0.10 par value	Payment of exercise	Dispose F	No	No	58.95	833	49.11 k	6,996
1 Feb 25	Gregory Scott Meyers	Common Stock, $0.10 par value	Option exercise	Acquire M	No	No	0	2,543	0.00	7,829
1 Feb 25	Gregory Scott Meyers	RSU Common Stock, $0.10 par value	Option exercise	Dispose M	No	No	0	2,543	0.00	2,543
1 Feb 25	Benjamin Hickey	Common Stock, $0.10 par value	Payment of exercise	Dispose F	No	No	58.95	3,725	219.59 k	7,133
1 Feb 25	Benjamin Hickey	Common Stock, $0.10 par value	Option exercise	Acquire M	No	No	0	10,078	0.00	10,858
1 Feb 25	Benjamin Hickey	RSU Common Stock, $0.10 par value	Option exercise	Dispose M	No	No	0	10,078	0.00	20,158
1 Feb 25	Arduini Peter J	Deferred Share Units Common Stock, $0.10 par value	Grant	Acquire A	No	No	58.95	3,562.341	210.00 k	60,937.918